ESC Professional Premium Access

Does prediabetes diagnosed by hemoglobinA1c or oral glucose tolerance test predict coronary artery disease in patients suspected of chronic coronary syndrome?

Congress Presentation

About the speaker

Doctor Katrine Schultz Overgaard

OUH Svendborg Hospital, Svendborg (Denmark)
0 follower

6 more presentations in this session

Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the SWEDEHEART-registry

Speaker: Doctor V. Ritsinger (Stockholm, SE)


Vessel-oriented cardiovascular events in patients with diabetes undergoing intracoronary physiology-guided revascularization

Speaker: Doctor S. Sgreva (Verona, IT)


Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention

Speaker: Doctor S. Moriya (Tokyo, JP)


Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies

Speaker: Doctor F. Moroni (Charlottesville, US) Doctor A. Abbate (Charlottesville, US)


Impact of diabetes status and chronic kidney disease on myocardial infarction mortality among elderly patients - a retrospective analysis of data from an ongoing nationwide registry.

Speaker: Doctor P. Asser (Tartu, EE)


Access the full session

Diabetes and stable coronary artery disease

Speakers: Doctor K. Overgaard, Doctor V. Ritsinger, Doctor S. Sgreva, Doctor S. Moriya, Doctor F. Moroni...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by